Wróblewska Anna, Bielawski Krzysztof Piotr, Sikorska Katarzyna
Laboratory of Photobiology and Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland.
Department of Tropical Medicine and Epidemiology, Faculty of Health Sciences, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Powstania Styczniowego 9b, 81-519 Gdynia, Poland.
J Clin Med. 2021 Dec 14;10(24):5874. doi: 10.3390/jcm10245874.
The sustained virologic response and elimination of HCV is widely viewed as a true cure of chronic hepatitis C as it associates with amelioration of histological liver damage and improved clinical outcomes. Therefore, the existence and clinical burden of occult HCV infection (OCI) has been a controversial issue for many years. In this review, we summarize recently published data that adds new information on the molecular and clinical background of OCI and its epidemiological significance. We also identify and discuss the most important methodological pitfalls, which can be a source of inconsistency between studies. Data that have accumulated so far, strongly support the existence of extrahepatic HCV replication in individuals negative for serum HCV-RNA by conventional clinical tests. OCI emerges as a condition where the immune system is unable to fully resolve infection but it is continuously stimulated by low levels of HCV antigens, leading to progression of liver pathology and extrahepatic HCV-related complications. Moreover, the development of monitoring strategies or management guidelines for OCI is still hampered by the lack of clear definition and the confusion regarding its clinical significance. Careful study design and the introduction of uniform protocols for the detection of low-level HCV-RNA are crucial for obtaining reliable data on OCI.
持续病毒学应答和丙型肝炎病毒(HCV)清除被广泛视为慢性丙型肝炎的真正治愈,因为它与肝脏组织学损伤的改善及临床结局的改善相关。因此,隐匿性HCV感染(OCI)的存在及其临床负担多年来一直是一个有争议的问题。在本综述中,我们总结了最近发表的数据,这些数据为OCI的分子和临床背景及其流行病学意义增添了新信息。我们还识别并讨论了最重要的方法学陷阱,这些陷阱可能是研究之间不一致的根源。迄今为止积累的数据有力地支持了在传统临床检测中血清HCV-RNA呈阴性的个体中存在肝外HCV复制。OCI表现为一种免疫系统无法完全清除感染,但持续受到低水平HCV抗原刺激的状态,导致肝脏病理进展和肝外HCV相关并发症。此外,由于缺乏明确的定义及其临床意义的混淆,OCI监测策略或管理指南的制定仍然受到阻碍。精心的研究设计以及引入统一的低水平HCV-RNA检测方案对于获得关于OCI的可靠数据至关重要。